Quantcast

Latest congenital heart disease Stories

2014-05-05 11:43:02

Data show risk for congenital anomalies highest among babies born to older women who smoke and heavy smokers Women who smoke during pregnancy may be putting their newborns at risk for congenital heart defects, and the more they smoke, the higher the risk, according to a study to be presented Saturday, May 3, at the Pediatric Academic Societies (PAS) annual meeting in Vancouver, British Columbia, Canada. Cigarette smoking during pregnancy has been linked to many birth defects, such as...

2014-04-29 23:07:45

Nobles Medical Technologies II today announced that it has received another Japanese Patent for its NobleStitch Technology. The patent is for the Suturing Devices and Methods for Closing a Patent Foramen Ovale (PFO) and shows the broad coverage of our method and apparatus for PFO Closure expanding to markets around the world. Fountain Valley, CA (PRWEB) April 29, 2014 Ben Brosch, President of NMT2 and co-inventor on the issued patent, commented, “We strive to protect our inventions with...

2014-04-29 23:05:57

New American Heart Association guidelines on diagnosis and treatment of fetal cardiac disease seek to improve care for babies with congenital heart disease. Philadelphia, Pa. (PRWEB) April 29, 2014 The important guidelines released by the AHA recently aim to improve care for babies with congenital heart disease while they are in the womb. Congenital heart defects are the most common birth defects, affecting one in 120 babies. As a leading Cardiac Center in the U.S., and renowned...

2014-04-26 23:03:01

Nobles Medical Technologies II, Inc. (NMT2) today announced that it has officially launched sales in Sweden for its NobleStitch EL PFO Closure System. NMT2 launched sales initially in Germany and the UK and will now be expanding this month into Sweden. Fountain Valley, California (PRWEB) April 26, 2014 Following a successful meeting at the Congress of Structural Interventions (CSI) congress in Frankfurt last June NMT2 received significant inquiries to bring its PFO technology to new...

2014-04-25 23:09:46

Nobles Medical Technologies II, Inc. (NMT2) today announced that it has received recertification of its ISO13485 and EN-ISO 14971 after a successful audit by its European notified body. This successful audit recertifies NMT2 to manufacture and sell its PFO Closure and suture products throughout the European Union. Fountain Valley, California (PRWEB) April 25, 2014 Prof. Dr. Anthony Nobles, CEO of NMT2 commented, “Our record in Regulatory Affairs and Quality Assurance worldwide shows our...

2014-04-22 23:01:58

Researchers at UC Davis Children’s Hospital have shown that children with Down syndrome have significantly better in-hospital survival rates after surgeries for congenital heart disease (CHD) than their genetically typical peers. Sacramento, CA (PRWEB) April 22, 2014 Researchers at UC Davis Children’s Hospital have shown that children with Down syndrome have significantly better in-hospital survival rates after surgeries for congenital heart disease (CHD) than their genetically...

2014-04-03 08:31:22

Seasoned Leader Brings More Than Three Decades of Experience to New Role PHILADELPHIA, April 3, 2014 /PRNewswire/ -- The Adult Congenital Heart Association (ACHA), a national nonprofit organization dedicated to improving and extending the lives of adults with congenital heart defects (CHD), announced today the appointment of Glenn R. Tringali as its new National Executive Director. Tringali comes to ACHA with more than three decades of extensive experience working with small,...

2014-03-31 12:28:59

U-M's Dr. Aimee Armstrong reports valve had low rates of narrowing, leakage, and other adverse events, during American College of Cardiology meeting ANN ARBOR, Mich., March 31, 2014 /PRNewswire-USNewswire/ -- The first post-FDA approval study of a non-surgically implanted replacement pulmonary valve showed strong short- and mid-term results for the device in patients with certain congenital heart defects, according to research presented by a U-M pediatric interventional cardiologist...

2014-03-27 23:29:49

Flood Law Group issued a statement today explaining that they are now available to investigate potential legal claims on behalf of parents of children with heart-related birth defects who took Zoloft during their pregnancy. According to a study from the New England Journal of Medicine, selective serotonin reuptake inhibitors (SSRIs) such as Zoloft have been linked to an increased risk of birth defects. Washington, DC (PRWEB) March 27, 2014 Flood Law Group today announced that they are now...

2014-03-14 23:26:08

HALVE a Heart For Kids! A fundraiser for Greg Olsen's HEARTest Yard Fund — 10 percent of the proceeds of sales at Chili's Grill and Bar on March 18th will benefit Greg Olsen's HEARTest Yard Fund. Charlotte, NC (PRWEB) March 14, 2014 Over 50 Chili’s Grill and Bar restaurants in North Carolina and South Carolina will be participating in an all-day fundraiser to help families with children who have congenital heart disease on Tuesday, March 18. The money raised will go...


Latest congenital heart disease Reference Libraries

Echocardiogram
2013-07-29 11:11:00

An echocardiogram is a test that, much like an ultrasound, uses sound waves to create a moving image of the heart. The most common type of echocardiogram is performed transthoracic, meaning the image is taken through a probe against the chest. A TTE does not involve radiation and is a very safe procedure. A cardiac sonographer will put a gel on the patient's chest and move the transducer around different areas, including directly anterior to the breastbone, inferior and lateral to the right...

More Articles (1 articles) »
Word of the Day
out-herod
  • In the phrase to out-herod Herod, to be more violent than Herod (as represented in the old mystery plays); hence, to exceed in any excess of evil.
Herod refers to 'Herod the Great,' a Roman client king and 'a madman who murdered his own family and a great many rabbis.' According to the OED, the term is 'chiefly with allusion to Shakespeare's use' in Hamlet.
Related